← Back to Vaccine Database

CYD Dengue Vaccine

Live attenuated vaccine · VDDBV0195

Target & Classification

DENVDengue virus
Live attenuated vaccine
Dengue Disease
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials23

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT02979535 Phase 3Dengue Disease
NCT02993757 Phase 3Dengue Disease
NCT00842530 Phase 2Dengue Disease
NCT01943825 Phase 2Dengue Disease
NCT00880893 Phase 2Dengue Disease
NCT02741128 Phase 2Dengue Disease
NCT02628444 Phase 2Dengue Disease
NCT02992418 Phase 3Dengue Disease
NCT00993447 Phase 2Dengue Disease
NCT00239577 Phase 2Dengue Disease
NCT01436396 Phase 3Dengue Disease
NCT01374516 Phase 3Dengue Disease
NCT01373281 Phase 3Dengue Disease
NCT01187433 Phase 2Dengue Disease
NCT01550289 Phase 2Dengue Disease
NCT01411241 Phase 3Dengue Disease
NCT01064141 Phase 2Dengue Disease
NCT01134263 Phase 3Dengue Disease
NCT01254422 Phase 3Dengue Disease
NCT01488890 Phase 2Dengue Disease
NCT00617344 Phase 2Dengue Disease
NCT04133987 Phase 2Dengue Disease
NCT00322049 Phase 2Dengue Disease